All Pharma News
price-trendAsk Us
SparingVision Reaches Final Dose Escalation Step in PRODYGY Trial

SparingVision Reaches Final Dose Escalation Step in PRODYGY Trial
GLOBENEWSWIRE
24 Jan 2024
Share Share
SparingVision Reports +ve Initial Safety Data from the first cohort Ph I/II

SparingVision Reports +ve Initial Safety Data from the first cohort Ph I/II
GLOBENEWSWIRE
30 Aug 2023
Share Share
SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics

SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics
GLOBENEWSWIRE
12 Jul 2023
Share Share
SparingVision appoints Joseph C. Papa as Chairman

SparingVision appoints Joseph C. Papa as Chairman
GLOBENEWSWIRE
05 Apr 2023
Share Share
SparingVision’s lead asset SPVN06 clears IND application in the US

SparingVision’s lead asset SPVN06 clears IND application in the US
GLOBENEWSWIRE
01 Dec 2022
Share Share
SparingVision’s lead asset SPVN06 clears IND application in the US

SparingVision’s lead asset SPVN06 clears IND application in the US
GLOBENEWSWIRE
01 Dec 2022
Share Share
SparingVision Raises €75 Million Series B to Continue Building World-Leading

SparingVision Raises €75 Million Series B to Continue Building World-Leading
GLOBENEWSWIRE
14 Sep 2022
Share Share
Intellia expands ocular pipeline with 10% stake in SparingVision

Intellia expands ocular pipeline with 10% stake in SparingVision
Kyle LaHucik FIERCEBIOTECH
14 Oct 2021
Share Share
SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of GAMUT

SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of GAMUT
GLOBENEWSWIRE
20 Apr 2021
Share Share
SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as CEO

SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as CEO
GLOBENEWSWIRE
20 Oct 2020
Share Share